These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 9195136
1. Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys. Tanaka H, Tanaka Y, Shinagawa K, Yamagishi Y, Ohtaki K, Asano K. Cytokine; 1997 May; 9(5):360-9. PubMed ID: 9195136 [Abstract] [Full Text] [Related]
2. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils. Zucca A, Brizzi S, Riccioni R, Azzarà A, Ghimenti M, Carulli G. Clin Ter; 2006 May; 157(1):19-24. PubMed ID: 16669548 [Abstract] [Full Text] [Related]
3. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor. Carulli G, Mattii L, Azzarà A, Brizzi S, Galimberti S, Zucca A, Benedetti E, Petrini M. Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714 [Abstract] [Full Text] [Related]
4. Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency. Nissen C. Eur J Cancer; 1994 May; 30A Suppl 3():S12-4. PubMed ID: 7535065 [Abstract] [Full Text] [Related]
5. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies. Tanaka H, Kaneko T. Drug Metab Dispos; 1991 May; 19(1):200-4. PubMed ID: 1708329 [Abstract] [Full Text] [Related]
11. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol. Eliason JF, Greway A, Tare N, Inoue T, Bowen S, Dar M, Yamasaki M, Okabe M, Horii I. Stem Cells; 2000 May; 18(1):40-5. PubMed ID: 10661570 [Abstract] [Full Text] [Related]
13. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression. Itoh Y, Kuratsuji T, Tsunawaki S, Aizawa S, Toyama K. Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects. Akizuki S, Mizorogi F, Inoue T, Sudo K, Ohnishi A. Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay. Tanaka H, Tokiwa T. J Pharmacol Exp Ther; 1990 Nov; 255(2):724-9. PubMed ID: 1700818 [Abstract] [Full Text] [Related]
16. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference? Höglund M. Med Oncol; 1998 Dec; 15(4):229-33. PubMed ID: 9951685 [Abstract] [Full Text] [Related]
17. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats. Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F. Cancer Chemother Pharmacol; 1997 Dec; 39(3):259-66. PubMed ID: 8996530 [Abstract] [Full Text] [Related]